Molecular engineering of proteins with predefined function. Part I: Design of a hemoglobin-based oxygen carrier.
Molecular engineering refers to a collection of complex, computer-based methods used to study molecular structures and properties. These methods include ones for determining properties as well as for accessing prior knowledge about them. Applying these methods, one can generate, manipulate and calculate the energy involved with the three-dimensional conformation of a given molecule. These computational tools were utilized in this study, to design cross-linking reagents for cell-free Hb, for the purpose of O(2)-carriers development. Hb, when removed from the red blood cell, misses some of its functional characteristics required. Yet, these characteristics can be rebuilt into the Hb molecule by appropriate chemical modifications. These modifications have been devised to prevent dimer formation, increase the retention time in circulation, and decrease the high oxygen affinity of free Hb. The reagent reported in this study, namely, oxidized-NAD (o-NAD), has been designed to fulfill both criteria of retention time and oxygen affinity, in a single package. Feasibility of the cross-linking reaction of o-NAD with Hb was assessed by studying the docking process of o-NAD within the 2,3-DPG pocket of Hb. In this study, we provide an insight into how the overall factors involved with the potential energy calculations contribute to the hydrogen bonding network, formed within the complex. Conformational search analysis has shown a high proximity, of functional moieties on the Hb molecule, to reactive groups on the o-NAD molecule suggested. This is an important step in the design and later synthesis of O(2)-carrying materials to be used as blood substitutes.
Sivan
Sarit
S
Department of Biomedical Engineering, The Leonard and Diane Sherman Center for Research in Biomaterials, Technion-Israel Institute of Technology, Haifa 32000, Israel.
Lotan
Noah
N
D019794:2,3-Diphosphoglycerate / Q000737:chemistry; D001665:Binding Sites; D040761:Biomimetic Materials / Q000138:chemical synthesis / Q000737:chemistry; D001802:Blood Substitutes / Q000138:chemical synthesis / Q000737:chemistry*; D003198:Computer Simulation; D015195:Drug Design; D005240:Feasibility Studies; D006454:Hemoglobins / Q000138:chemical synthesis / Q000737:chemistry*; D008958:Models, Molecular; D008970:Molecular Weight; D009243:NAD / Q000031:analogs & derivatives / Q000737:chemistry*; D010084:Oxidation-Reduction; D010100:Oxygen / Q000737:chemistry*; D011485:Protein Binding; D011487:Protein Conformation; D015202:Protein Engineering / Q000379:methods*
D001802:Blood Substitutes; D006454:Hemoglobins; D009243:NAD; D019794:2,3-Diphosphoglycerate; D010100:Oxygen